Literature DB >> 4619579

Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma.

R L Comis, S K Carter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4619579     DOI： 10.1016/s0305-7372(74)80020-4

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  10 in total

Review 1.  Chemotherapy of malignant melanoma.

Authors:  R S Benjamin
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

Review 2.  Recent developments in oral chemotherapy options for gastric carcinoma.

Authors:  J A Ajani; H Takiuchi
Journal:  Drugs       Date:  1999       Impact factor: 9.546

3.  Vindesine as a single agent in the treatment of advanced malignant melanoma.

Authors:  S Retsas; K A Newton; G Westbury
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique.

Authors:  V Sigurdardóttir; C Bolund; Y Brandberg; M Sullivan
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

5.  Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma.

Authors:  D A Amato; H Bruckner; D Guerry; A Ash; G Falkson; E C Borden; R H Creech; E D Savlov; T J Cunningham
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

Review 6.  Chemotherapy of oesophago-gastric cancer.

Authors:  P J Ross; S Rao; D Cunningham
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

7.  Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: a randomized phase II study.

Authors:  U Ringborg; C M Rudenstam; J Hansson; L Hafström; B Stenstam; H Strander
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

8.  Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.

Authors:  E S Newlands; C J Oon; J T Roberts; P Elliott; R F Mould; C Topham; F J Madden; K A Newton; G Westbury
Journal:  Br J Cancer       Date:  1976-08       Impact factor: 7.640

9.  A new melanoma seeker for possible clinical use: selective accumulation of radiolabelled thiouracil.

Authors:  L Dencker; B Larsson; K Olander; S Ullberg
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

10.  Malignant melanoma: sex differences in survival after evidence of distant metastasis.

Authors:  F Rampen
Journal:  Br J Cancer       Date:  1980-07       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.